ArticleBreast cancer (Tokyo, Japan)2026
Investigating the shared genetic architecture and causality of breast cancer and thyroid cancer: genome-wide cross trait analysis and bi-directional Mendelian randomization study.
Article in Breast cancer (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAn epidemiological association between breast cancer (BC) and thyroid cancer (TC) has been found in several observational studies, but whether they share common genetic factors remain unknown. Our research aimed to investigate the shared genetic architecture and potential causal link between BC, including estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) subtypes, and TC.
methodsUsing genome-wide association study (GWAS) summary statistics, we examined the genetic correlation of BC and TC through linkage disequilibrium score regression (LDSC), Heritability Estimation from Summary Statistics (ρ-HESS), and stratified LDSC (S-LDSC). Shared risk single-nucleotide polymorphisms (SNPs) were obtained using cross-trait meta-analysis with Multi-trait Analysis of GWAS (MTAG) and Cross Phenotype Association (CPASSOC). Co-localization analysis was used to identify shared causal genetic variants. Functional annotation and tissue-specific SNP heritability enrichment analysis was used to investigate SNP enrichment at the molecular and tissue levels. Causality was determined by bidirectional Mendelian randomization.
resultsA significant, positive global genetic correlation between BC and TC was identified, and was also confirmed in the ER+ subtype. Local genetic correlation analysis identified strong signals in the 2q35 region encompassing rs13387042 (TNP1) and rs966423 (DIRC3). Cross-trait meta-analysis uncovered 23 risk SNPs. Co-localization analysis indicated shared causal variants with high posterior probabilities of shared causality. Gene Ontology enrichment analysis identified significant enrichment in cell cycle G1/S phase transition regulation and Wnt signaling pathway. Bidirectional Mendelian randomization suggested a significant association between BC genetic liability and increased TC risk, particularly in the ER+ subtype.
conclusionOur study identified a genetic correlation, shared risk genes, and potential causal connection between BC and TC. These findings offered perspectives on the possible mechanisms underlying their comorbidity and the future development of therapeutics.
Indexed as
Identifiers
42133267What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.